marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Panbela Therapeutics Cash Flow 2011-2024 | PBLA
Annual Cash Flow Panbela Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-25.2 M | -15.3 M | -7.24 M | -3.85 M | -2.74 M | -2.39 M | -3.4 M | -2.4 M | - | -11.5 K | -35.4 K | 37.1 K | -73 K |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | 9.58 K | 8.79 K | 5.64 K | 3.1 K |
Accounts Payables |
9.94 M | 2.86 M | 640 K | 554 K | 597 K | 1.06 M | 1.2 M | 1.24 M | 585 K | 340 | 4 K | 28.1 K | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | 18.1 K | 14.8 K | 75.5 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Panbela Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -9.39 M | - | - | - | -9.75 M | - | -10.3 M | -8.68 M | -4.48 M | - | -5.02 M | -3.66 M | -1.96 M | - | -2.74 M | -1.98 M | -1.12 M | - | -1.87 M | -1.41 M | -783 K | - | -2.22 M | -1.58 M | -588 K | - | -2.62 M | -2.36 M | -1.07 M | - | -1.57 M | - | - | - | - | - | 95.9 K | - | - | 32.6 K | 16.4 K | - | -138 K | -135 K | -87.5 K | - | 70.9 K | 79.8 K | -27.8 K | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.15 K | - | - | 5 K | 2.66 K | - | 6.13 K | 4.09 K | 2.12 K | - | 3.62 K | 2.32 K | - | - | - | - | - |
Accounts Payables |
11 M | 14.3 M | 8.51 M | 9.94 M | 6.61 M | 8.44 M | 7.34 M | 2.86 M | 5.39 M | 3.21 M | 3.99 M | 640 K | 796 K | 781 K | 782 K | 554 K | 554 K | 554 K | 554 K | 597 K | 597 K | 597 K | 597 K | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 585 K | 585 K | 585 K | 585 K | 297 K | 335 K | 340 | 340 | 4 K | 4 K | 4 K | 4 K | 28.1 K | 28.1 K | 28.1 K | 28.1 K | 38.7 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12 K | 32.6 K | 18.1 K | 17.4 K | 15.7 K | 18.1 K | 14.8 K | 14.8 K | 14.8 K | 14.8 K | 75.5 K | 75.5 K | 75.5 K | 75.5 K | 42.6 K | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency